Edap Tms

Edap Tms R&D per Employee

The R&D Spending per Employee of Edap Tms (EDAP) as of Oct 10, 2026 is 29,584.78 EUR. In the previous year, R&D Spending per Employee was 30,964.96 EUR — a change of -4.46% (lower).

R&D per Employee

29,584.78EUR

YoY

-4.46%

Last updated:

R&D Spending per Employee of Edap Tms is 2025 29,584.78 EUR. R&D Spending per Employee of Edap Tms was 2024 30,964.96 EUR. It decreases by -4.46% lower compared to the previous year.

The Edap Tms R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
16,384.25 EUR
Jan 1, 2019
14,941.41 EUR
Jan 1, 2020
18,019.47 EUR
Jan 1, 2021
19,065.53 EUR
Jan 1, 2022
19,718.82 EUR
Jan 1, 2023
27,906.93 EUR
Jan 1, 2024
30,964.96 EUR
Jan 1, 2025
29,584.78 EUR
The Edap Tms R&D per Employee history
YEARR&D per EmployeeYoY
29,584.78EUR-4.46%
30,964.96EUR+10.96%
27,906.93EUR+41.52%
19,718.82EUR+3.43%
19,065.53EUR+5.81%
18,019.47EUR+20.60%
14,941.41EUR-8.81%
16,384.25EUR+5.33%
15,554.62EUR+0.34%
15,502.52EUR+43.79%
10,781.22EUR-8.25%
11,751.13EUR—
Access this data via the Eulerpool API

Edap Tms Stock analysis

What does Edap Tms do? Edap Tms SA is a French company specialized in the development and marketing of medical devices. The company was founded in 1979 and has its headquarters in Vaulx-en-Velin, France. With over 300 employees, Edap Tms SA operates worldwide and has branches in the USA, Asia, and Europe. The company's business model is based on the development of non-invasive medical devices, particularly HIFU (High-Intensity Focused Ultrasound) devices. With its technology, the company has developed a revolutionary new procedure for tumor treatment that can replace traditional radiation therapy. HIFU offers a gentler and more precise alternative for tumor treatment without damaging the surrounding tissue. Edap Tms SA offers its products and services in four main business areas: 1. HIFU systems for the treatment of prostate cancer: Edap Tms SA has developed a HIFU system capable of treating prostate cancer without invasive procedures. The system uses a special ultrasound probe inserted into the rectum to locate the tumor and direct targeted sound waves at the tumor, destroying cancer cells. 2. HIFU systems for the treatment of kidney cancer: Edap Tms SA has also developed a HIFU system capable of treating kidney cancer tumors. It works similarly to the prostate cancer system, effectively destroying the tumor through targeted sound waves. 3. Mobile HIFU devices: Edap Tms SA has developed mobile HIFU devices suitable for use in hospitals and clinics. These devices can be quickly and easily transported from room to room, allowing medical professionals to perform HIFU treatments without the need for additional equipment. 4. Bladder cancer treatment technology: Edap Tms SA has also developed technology used in the treatment of bladder cancer. The system also utilizes HIFU technology to destroy tumor cells, but it is introduced through the urethra and focuses on the tumor in the bladder. Edap Tms SA is a global leader in the development and marketing of HIFU systems. The company aims to improve cancer treatment and provide patients with a more effective and gentler alternative to traditional radiation therapy. With a wide range of products suitable for various types of cancer and a strong presence in the USA, Europe, and Asia, Edap Tms SA is a highly regarded brand in the medical device field. Overall, Edap Tms SA is a company with a rich history that focuses on innovative technologies and continuously strives to improve the lives of cancer patients. With its HIFU portfolio and strong market presence, the company is on track to achieve its goals and solidify its position as one of the leading providers of medical devices worldwide. Edap Tms is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Edap Tms stock

R&D Spending per Employee of Edap Tms is 29,584.78 EUR in 2025.

R&D Spending per Employee of Edap Tms changed from 30,964.96 EUR to 29,584.78 EUR, representing a -4.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Edap Tms since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Edap Tms historically and in real time.

Access this data via the Eulerpool API

Workforce — Edap Tms

All Key Metrics — Edap Tms